AMAG Pharmaceuticals organizacji EBIT margin
Jaka jest wartość EBIT margin organizacji AMAG Pharmaceuticals?
Wartość EBIT margin organizacji AMAG Pharmaceuticals, Inc. to -66.23%
Jaka jest definicja EBIT margin?
EBIT margin is a profitability ratio that measures earnings of the company as a percentage of revenue without taking into account the effect of taxes and interest.
ttm (trailing twelve months)
EBIT margin measures the profitability and operational efficiency of a company. It compares the amount of money that remains after the cost of goods and all operating expenses are subtracted from net revenue to sales. EBIT margin is calculated as earnings before interest and taxes divided by net revenue.
EBIT and EBIT margin evaluate how well a business manages its operations. Interest and taxes are not operating expenses and don’t impact operating efficiency. EBIT margin is usually used to compare operational efficiency and profitability of companies within the same industry. Taxes can vary by location thus excluding them from the calculation gives a better basis for comparing different companies.
EBIT and operating income are often used interchangeably, but there is a difference between them, which can cause the numbers to give different results. The key difference is that operating income does not include non-operating income, non-operating expenses, and other income.
EBIT margin firm w Health Care sektor na NASDAQ w porównaniu do AMAG Pharmaceuticals
Czym się zajmuję organizacja AMAG Pharmaceuticals?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Firmy z ebit margin podobne do AMAG Pharmaceuticals
- Wartość EBIT margin organizacji Senmiao Technology Ltd to -66.36%
- Wartość EBIT margin organizacji Take-Two Interactive Software to -66.33%
- Wartość EBIT margin organizacji Collagen Solutions plc to -66.31%
- Wartość EBIT margin organizacji Guyana Goldfields to -66.31%
- Wartość EBIT margin organizacji Tilray to -66.31%
- Wartość EBIT margin organizacji GSI Technology Inc to -66.30%
- Wartość EBIT margin organizacji AMAG Pharmaceuticals to -66.23%
- Wartość EBIT margin organizacji Amicus Therapeutics to -66.22%
- Wartość EBIT margin organizacji Forbidden Foods to -66.16%
- Wartość EBIT margin organizacji ASA Gold and Precious Metals Ltd to -66.12%
- Wartość EBIT margin organizacji SimiGon to -66.07%
- Wartość EBIT margin organizacji Drone Volt SA to -65.98%
- Wartość EBIT margin organizacji Vision Cinemas to -65.87%